Spots Global Cancer Trial Database for folfiri protocol
Every month we try and update this database with for folfiri protocol cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase 2 Trial of SCO-101 in Combination With FOLFIRI for Patients With Metastatic Colorectal Cancer (mCRC) With Acquired Resistance to FOLFIRI | NCT04247256 | Metastatic Colo... | FOLFIRI Protoco... SCO-101 | 18 Years - | Scandion Oncology A/S | |
| Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma | NCT03959293 | Gastric Adenoca... Gastric Cancer | Durvalumab Tremelimumab FOLFIRI Protoco... | 18 Years - | Federation Francophone de Cancerologie Digestive | |
| Efficacy and Safety of Aflibercept in Combination With FOLFIRI Chemotherapy as 1st Line Treatment for Patients With Metastatic Colorectal Cancer | NCT02181556 | Metastatic Colo... | FOLFIRI Protoco... Aflibercept Inj... | 18 Years - | Federation Francophone de Cancerologie Digestive | |
| Study to Evaluate the Efficiency of FOLFIRI as Seconde-line Chemotherapy in Neuroendocrine Carcinoma | NCT03168607 | Neuroendocrine ... | FOLFIRI Protoco... | 18 Years - | Peking University | |
| Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC | NCT04587128 | Metastatic Colo... | Panitumumab Cetuximab Irinotecan FOLFIRI Protoco... Bevacizumab | 18 Years - | University of Wisconsin, Madison | |
| Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer | NCT03186326 | Metastatic Colo... MSI | FOLFOX regimen FOLFIRI Protoco... Avelumab Panitumumab Cetuximab Bevacizumab Aflibercept | 18 Years - | Federation Francophone de Cancerologie Digestive | |
| A Health Service Research Study to Investigate Survival of Metastatic Pancreatic Cancer Patients After Sequential Chemotherapy | NCT03331640 | Metastatic Panc... | OFF FOLFIRI Protoco... | 18 Years - | AIO-Studien-gGmbH | |
| SI-B001 as a Single Agent or in Combination With Chemotherapy in the Treatment of Digestive System Malignancies | NCT05039944 | Colorectal Canc... | SI-B001 Irinotecan FOLFIRI Protoco... FOLFOX Protocol | 18 Years - | Sichuan Baili Pharmaceutical Co., Ltd. | |
| Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer | NCT03803553 | Metastatic Colo... Stage III Colon... | FOLFIRI Protoco... ACTIVE SURVEILL... Nivolumab Proto... Encorafenib/Bin... Trastuzumab + P... | 18 Years - | Massachusetts General Hospital | |
| A Health Service Research Study to Investigate Survival of Metastatic Pancreatic Cancer Patients After Sequential Chemotherapy | NCT03331640 | Metastatic Panc... | OFF FOLFIRI Protoco... | 18 Years - | AIO-Studien-gGmbH | |
| Treatment With Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic FOLFIRI Chemotherapy and Bevacuzimab in Patients With Liver-only Colorectal Liver Metastases (CRLM): Conversion to Complete Resection in Patients With Initially Inoperable Liver-only CRLM. | NCT04003792 | Liver Metastasi... | oxaliplatin FOLFIRI Protoco... Bevacizumab | 18 Years - | Rabin Medical Center | |
| Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC | NCT04587128 | Metastatic Colo... | Panitumumab Cetuximab Irinotecan FOLFIRI Protoco... Bevacizumab | 18 Years - | University of Wisconsin, Madison | |
| Treatment With Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic FOLFIRI Chemotherapy and Bevacuzimab in Patients With Liver-only Colorectal Liver Metastases (CRLM): Conversion to Complete Resection in Patients With Initially Inoperable Liver-only CRLM. | NCT04003792 | Liver Metastasi... | oxaliplatin FOLFIRI Protoco... Bevacizumab | 18 Years - | Rabin Medical Center | |
| SI-B001 as a Single Agent or in Combination With Chemotherapy in the Treatment of Digestive System Malignancies | NCT05039944 | Colorectal Canc... | SI-B001 Irinotecan FOLFIRI Protoco... FOLFOX Protocol | 18 Years - | Sichuan Baili Pharmaceutical Co., Ltd. | |
| RP-6306 in Patients With Advanced Cancer | NCT05605509 | Advanced Cancer | RP-6306 Gemcitabine FOLFIRI Protoco... Trastuzumab | 18 Years - | Canadian Cancer Trials Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
